<unk>  is a granulocyte colony stimulating factor that is FDA approved for the treatment of infection in patients with non-myeloid malignancies.   Common adverse reactions include bone pain and extremity pain.
Pegfilgrastim
Filgrastim
Tbo-filgrastim
Interferon alfa-2a
Romiplostim
Interferon beta-1a
Interferon Alfa-n3
Aldesleukin